Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study.
Carlos FerrandoRicard Mellado-ArtigasAlfredo GeaEgoitz ArrutiCésar AldecoaRamón AdaliaFernando RamascoPablo MonederoEmilio MasedaGonzalo TamayoMaría L Hernández-SanzJordi MercadalAscensión Martín-GrandeRobert M KacmarekJesús VillarFernando Suárez-Sipmannnull nullPublished in: Critical care (London, England) (2020)
In patients with COVID-19 ARF treated with HFNO, the use of awake-PP did not reduce the need for intubation or affect mortality.